UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database

Hepatology (Baltimore, Md.), 2011-08, Vol.54 (2), p.463-471

2011

Volltextzugriff (PDF)

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States

The American journal of gastroenterology, 2013-08, Vol.108 (8), p.1314-1321

2013

Volltextzugriff (PDF)

Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

Hepatology (Baltimore, Md.), 2015-07, Vol.62 (1), p.243-252

2015

Volltextzugriff (PDF)

Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study

PloS one, 2018-11, Vol.13 (11), p.e0207162-e0207162

2018

Volltextzugriff (PDF)

Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response

PloS one, 2017-02, Vol.12 (2), p.e0171755-e0171755

2017

Volltextzugriff (PDF)

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

Gut, 2017-10, Vol.66 (10), p.1844

2017

Volltextzugriff (PDF)

Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control Study

Clinical gastroenterology and hepatology, 2007-10, Vol.5 (10), p.1221-1228

2007

Volltextzugriff (PDF)

New therapeutic strategies in HCV: polymerase inhibitors

Liver international, 2013-02, Vol.33 (s1), p.85-92

2013

Volltextzugriff (PDF)

Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry

PloS one, 2017-10, Vol.12 (10), p.e0186898-e0186898

2017

Volltextzugriff (PDF)

Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials

Liver international, 2020-04, Vol.40 (4), p.778-786

2020

Volltextzugriff (PDF)

Impact of Classification of Hilar Cholangiocarcinomas (Klatskin Tumors) on the Incidence of Intra- and Extrahepatic Cholangiocarcinoma in the United States

JNCI : Journal of the National Cancer Institute, 2006-06, Vol.98 (12), p.873-875

2006

Volltextzugriff (PDF)

Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study

International journal of cancer, 2007-02, Vol.120 (3), p.638-641

2007

Volltextzugriff (PDF)

Global Epidemiology of HCV Subtypes and Resistance-associated Substitutions Evaluated by Sequencing-Based Subtype Analyses

Journal of hepatology, 2017-08, Vol.67 (2), p.224-236

2017

Volltextzugriff (PDF)

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

Journal of hepatology, 2020-04, Vol.72 (4), p.688-701

2020

Volltextzugriff (PDF)

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Gut, 2016-11, Vol.65 (11), p.1861-1870

2016

Volltextzugriff (PDF)

Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure

Hepatology (Baltimore, Md.), 2016-10, Vol.64 (4), p.1249-1264

2016

Volltextzugriff (PDF)

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2019-07, Vol.157 (1), p.149-162

2019

Volltextzugriff (PDF)

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Hepatology (Baltimore, Md.), 2015-07, Vol.62 (1), p.79-86

2015

Volltextzugriff (PDF)

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients

Antiviral research, 2014-11, Vol.111, p.53-59

2014

Volltextzugriff (PDF)

Real-Time PCR Assay for Detection and Quantification of Hepatitis B Virus Genotypes A to G

Journal of Clinical Microbiology, 2006-09, Vol.44 (9), p.3325-3333

2006

Volltextzugriff (PDF)

Mixing and Matching Drugs: What Makes Sense?

Clinics in liver disease, 2011-08, Vol.15 (3), p.657-664

2011

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(68)
Buchkapitel
(5)

Sprache

Englisch
(69)
Japanisch
(14)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(48)
Humans
(43)
Female
(32)
Male
(31)
Middle Aged
(27)
Gastroenterology & Hepatology
(26)
Adult
(24)
Aged
(22)
Hepatitis C, Chronic - Drug Therapy
(15)
Infectious Diseases
(14)
Liver Diseases
(13)
Virology
(13)
Biological And Medical Sciences
(12)
Drug Therapy, Combination
(12)
Hepacivirus - Genetics
(12)
Hepatitis
(11)
Hepatitis C
(11)
Hepatitis C Virus
(11)
Liver Cirrhosis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States

Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study

Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control Study

New therapeutic strategies in HCV: polymerase inhibitors

Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry

Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials

Impact of Classification of Hilar Cholangiocarcinomas (Klatskin Tumors) on the Incidence of Intra- and Extrahepatic Cholangiocarcinoma in the United States

Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study

Global Epidemiology of HCV Subtypes and Resistance-associated Substitutions Evaluated by Sequencing-Based Subtype Analyses

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients

Real-Time PCR Assay for Detection and Quantification of Hepatitis B Virus Genotypes A to G

Mixing and Matching Drugs: What Makes Sense?

Suchergebnisse filtern